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Aims Local activation time (LAT) mapping forms the cornerstone of atrial tachycardia diagnosis. Although anatomic and
positional accuracy of electroanatomic mapping (EAM) systems have been validated, the effect of electrode sam-
pling density on LAT map reconstruction is not known. Here, we study the effect of chamber geometry and activa-
tion complexity on optimal LAT sampling density using a combined in silico and in vivo approach.
...................................................................................................................................................................................................
Methods
and results
In vivo 21 atrial tachycardia maps were studied in three groups: (1) focal activation, (2) macro-re-entry, and (3)
localized re-entry. In silico activation was simulated on a 44cm atrial monolayer, sampled randomly at 0.25–10
points/cm2 and used to re-interpolate LAT maps. Activation patterns were studied in the geometrically simple por-
cine right atrium (RA) and complex human left atrium (LA). Activation complexity was introduced into the porcine
RA by incomplete inter-caval linear ablation. In all cases, optimal sampling density was defined as the highest density
resulting in minimal further error reduction in the re-interpolated maps. Optimal sampling densities for LA tachy-
cardias were 0.67 ± 0.17 points/cm2 (focal activation), 1.05 ± 0.32 points/cm2 (macro-re-entry) and
1.23 ± 0.26 points/cm2 (localized re-entry), P= 0.0031. Increasing activation complexity was associated with
increased optimal sampling density both in silico (focal activation 1.09 ± 0.14 points/cm2; re-entry 1.44 ± 0.49 points/
cm2; spiral-wave 1.50 ± 0.34 points/cm2, P< 0.0001) and in vivo (porcine RA pre-ablation 0.45 ± 0.13 vs. post-
ablation 0.78 ± 0.17 points/cm2, P= 0.0008). Increasing chamber geometry was also associated with increased opti-
mal sampling density (0.61 ± 0.22 points/cm2 vs. 1.0 ± 0.34 points/cm2, P= 0.0015).
...................................................................................................................................................................................................
Conclusion Optimal sampling densities can be identified to maximize diagnostic yield of LAT maps. Greater sampling density is
required to correctly reveal complex activation and represent activation across complex geometries. Overall, the
optimal sampling density for LAT map interpolation defined in this study was 1.0–1.5 points/cm2.
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Introduction
Local activation time (LAT) mapping forms the of cornerstone com-
plex atrial tachycardia diagnosis. The creation of LAT maps by elec-
troanatomic mapping (EAM) systems involves four key steps: (1)
creation of a three dimensional anatomy model, (2) analysis of intra-
cardiac electrograms to identify activation times relative to a fixed
temporal reference, (3) interpolation of the activation times across
the anatomical model, and (4) representation of the interpolated
data, usually in the form of a colour map. Anatomic accuracy of LA
EAM chamber models has been compared to cross sectional imaging
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with CT/MRI,1 showing faithful representation of pulmonary vein di-
mensions and geometry. Similarly, catheter localization accuracy
within EAM systems has been shown to be both reproducible and ac-
curate.2 To date however, no studies have examined the accuracy of
interpolated LAT maps generated with contact mapping. Rather, rec-
ommendations on the number of sampling locations required to cre-
ate an accurate map are primarily based on operator experience.3
Meanwhile, device manufacturers continue to innovate to increase
the achievable resolution of mapping systems4,5 but the end goal of
effective diagnosis and treatment whilst minimizing procedure times
remains unchanged.
Therefore, this study presents an optimal point sampling strategy
for atrial tachycardias, based on systematic analysis of in silico and
in vivo LAT mapping data. We defined optimal density as the sampling
density required for interpolation of an accurate LAT map whilst not
sacrificing efficiency by oversampling and hypothesized that an opti-
mal activation sampling density exists beyond which further sampling
is of limited clinical benefit. The impact of chamber geometry and ac-
tivation pattern complexity on the optimal LAT sampling density
required for mapping ATs is examined.
Methods
In vivo procedures
A total of 37 electroanatomic maps were included in the analysis.
Isochronal local activation time maps were created using the Carto3
mapping system (Biosense Webster, Diamond Bar, CA, USA) by taking
the activation time at each acquired point as the time from reference acti-
vation (typically an atrial coronary sinus electrogram) to the earliest rapid
deflection on the bipolar mapping catheter signal.
Mapping data was analysed from 21 patients undergoing clinically-
indicated ablation for left atrial tachycardia. Cases with high quality maps
(defined as maps with complete LA coverage) were identified retrospect-
ively and all identified cases were included in the analysis. Following trans-
septal puncture, a 20-pole circular mapping catheter (Lasso Nav,
Biosense Webster, Diamond Bar, CA, USA) was used to create a 3D
geometry of the left atrium. High-density local activation time maps were
constructed with the multipolar mapping catheter during tachycardia.
Local activation times were automatically assigned and all points were re-
annotated offline to ensure correct identification of the first component
of each electrogram. Correct tachycardia diagnosis was confirmed by
LAT map appearance, response to entrainment manoeuvres and re-
sponse to ablation. Informed written consent was obtained from all pa-
tients for invasive procedures.
Animal studies complied fully with Danish law on animal experiments.
Eight Go¨ttingen mini-pigs (41.2 ± 7.2 kg) were pre-sedated with intramus-
cular azaperone (4 mg/kg) and midazolam (0.5 mg/kg). General anaesthe-
sia was induced with intravenous ketamine (5 mg/kg) and midazolam
(0.5 mg/kg). Anaesthesia was maintained with a continuous intravenous
infusion of propofol (3 mg/kg/h) and fentanyl (15 lg/kg/h). Two 8F
sheaths were placed percutaneously in the right femoral vein, followed
by an intravenous injection of 100 IU/kg heparin. Fluoroscopy was used
to position a 6F decapolar reference catheter in the coronary sinus (CS)
and a 7.5F ablation catheter was advanced to the RA and used to create a
LAT map during proximal CS pacing. Incomplete inter-caval linear abla-
tion (confirmed with pace mapping) was performed, with a deliberate 5
mm gap left between cranial and caudal aspects of the lesion, before re-
peat LAT mapping of the new activation detour was performed.
Atrial monolayer model
A 4  4cm atrial tissue model was meshed using triangular elements
(84 346 triangles, 42 511 nodes, average edge length Dl = 0.2 mm). To
simulate electrical activation of atrial tissue by an extracellular stimulus
(1000 mV, 1 ms duration), the period of electrical activation was mod-
elled using the bi-domain equations given by:
r  riruiÞ ¼ bImð
r  rerueÞ ¼  bImð
Im ¼ Cm oVmot þ Iion
Vm ¼ ui  ue
where ri and reare the intra and extracellular conductance tensors, re-
spectively, b is the surface to volume ratio (1400 cm-1), ui and ue are
intra and extra cellular potentials, respectively, Im is the transmembrane
current, Cm is the membrane capacitance (0.01 mF mm
-2), Vm is the trans-
membrane potential and Iion is the cellular ionic current simulated using
the Nygren et al., atrial electrophysiology cellular model.6 The conduction
tensors are aligned with the local tissue microstructure orientation with
intracellular fibre and cross-fibre conduction set to 0.28 and 0.026 S/m,
respectively. The extracellular fibre and cross-fibre conduction were set
to 0.22 and 0.13 S/m, respectively, for linear and focal activation patterns.7
In the tissue model the fibre direction was aligned parallel to the x-axis.
Isotropic conduction with equal intra and extracellular conductivities of
0.15 S/m was employed for re-entrant and spiral wave activation patterns
in order to facilitate the production of stable re-entrant waves within the
44 cm monolayer domain.8 Following stimulation to reduce computa-
tional load, the model reverts to the mono-domain equations:
What’s new
• Electroanatomic mapping advances allow many hundreds, or
possibly thousands, of activation time points to be collected
within a single local activation time (LAT) map;
• Whether such an exponential increase in LAT sampling density
results in similar increases in LAT map accuracy is not known;
• This manuscript defines the optimal sampling density for atrial
tachyarrhythmias as the maximal density beyond which further
sampling produces minimal further improvement in interpo-
lated LAT map accuracy;
• Optimal sampling densities are thereby determined for a var-
iety of tachycardia mechanisms, and are found to be in the
range of 1.0–1.5 points/cm2;
• Therefore, we propose that when a diagnosis is not reached
at this density, further sampling may be less likely to improve
map accuracy than a change of mapping strategy (e.g. a differ-
ent window of interest, reference electrogram or LAT assign-
ment technique).
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r  rrVmð Þ þ Istim ¼ b Cm oVmot þ Iion
 
;
where r is the conductivity tensor and the fibre and cross fibre conduct-
ivity is set to the harmonic mean intra and extra cellular conductivities giv-
ing fibre and cross fibre values of 0.1232 and 0.0217 S/m, respectively (or
0.075 S/m for isotropic conduction). Electrical propagation was deter-
mined by solving the bidomain and monodomain equations using the fi-
nite element method. The model was discretized in space with linear
finite elements; the non-linear term describing the ionic current was
treated with a splitting technique.9 The ionic model was discretized in
time with a forward-Euler scheme and a time step of 5 ms, while the par-
tial differential equations were solved with a time step of dt= 10 ms. The
numerical simulations were performed with the Cardiac Arrhythmia
Research Package (CARP) solver.
To create uniform linear activation, a 2 mm region at the left edge of
the tissue was stimulated. To create focal activation a 11mm region close
to the centre of the monolayer was stimulated. To create re-entry, a circu-
lar non-conducting region (diameter 1.5 cm) was introduced in the mono-
layer and a dual stimulus protocol was used to initiate re-entry. To create
spiral wave activation, two linear stimuli were used. The first stimulus acti-
vated the entire extent of the leftmost edge of the monolayer, whist the
second critically timed stimulus initiated spiral wave re-entry. In silico iso-
chronal maps (see leftmost column, Figure 6) were constructed from the
transmembrane potential fields by calculating the time elapsed between a
fixed temporal reference and the time at which the transmembrane po-
tential exceeded a pre-defined voltage threshold (-20 mV).
Local activation map construction
Re-interpolated LAT maps were created by down-sampling the number
of acquired points and performing linear interpolation of the resulting ac-
tivation field across the 2D domain for the simulated activation patterns
or 3D geometry (i.e. electroanatomic shell) for the clinical arrhythmias.
For locations beyond the outermost re-sampled points linear extrapola-
tion based on boundary gradients was used to calculate activation times.9
The scatteredInterpolant class (MATLAB 8.2, The Mathworks Inc.,
Natick, MA) was used to implement interpolation and extrapolation
methods. When performing re-interpolation on the clinical datasets, a
‘region of electrical interest’ was defined as all the nodes of the electroa-
natomic map lying within 10 mm of an original electrical mapping point.
During re-interpolation, the interpolant was only interrogated for mesh
nodes lying within this region. Points out-with this region were assigned
indeterminate local activation times and are represented as grey in the ac-
companying figures.
Optimal LAT sampling density
measurement
For simulated activation patterns, we defined the reference map as the
high-resolution isochronal map created from the activation times calcu-
lated at every mesh node. For clinical activation patterns, we defined the
reference map as the LAT map created by the clinical mapping system
using all available LAT points. Reference and re-interpolated maps were
compared quantitatively by computing the sum of squared differences be-
tween activation times at every mesh node in the region of electrical
interest of the chamber model. Results are presented per node (average
LAT map error, ms/node) in order to normalize for inter-case differences
in the number of nodes per geometry.
The optimal sampling density for each LAT map was defined as the
highest sampling density resulting in minimal further error reduction in
the re-interpolated maps (defined as an error reduction rate of <0.05 ms
per mesh node per additional point sampled). This threshold represents
a LAT interpolation error of 1% assuming maximal sampling density of 4
points/cm2 and typical conduction velocity of 1 ms-1. Calculation of the
error reduction rate was made as shown in Figure 2. First, each map was
re-interpolated with point sampling densities in the range 0.25–10 points/
cm2 (step size 0.125 points/cm2, simulated data repetitions = 100; clinical
data repetitions = 10). For each repetition, sample points were distrib-
uted randomly across the mapping domain. The mean LAT map accuracy
(see above) for each density was plotted against sampling density and a
power law of the form f sð Þ ¼ asb þ c was fitted to the resulting mean
accuracies (where s is the sampling density and a, b, and c are fitted
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Figure 1 Optimal LAT sampling densities. Calculated optimal LAT sampling densities are shown for simulated activation patterns (A) and in vivo LA
activation patterns (B). FO, focal origin; MA, macro re-entry; MI, micro (localised) re-entry.
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parameters). A power law was chosen owing to the observed distribu-
tion of the average LAT map error and to permit an analytical determin-
ation of optimal sampling density that was less sensitive to noise. Taking
the first derivative of this function (i.e. f
0
sð Þ ¼ absb1) gives the improve-
ment in map accuracy per node relative to an increase in sampling density.
This equation was solved for f
0
sð Þ ¼ 0:05 ms/node/Ddensity, in order
to determine the sampling density at which minimal further improvement
in map accuracy is achieved by further point sampling.
Electroanatomic surface area calculation
Left atrial cardiac chamber models were exported from the Carto3 map-
ping system and imported into MATLAB 8.2 (The Mathworks Inc., Natick,
MA) using custom-written software. The total surface area of the chamber
was calculated as the summation of the areas of all triangles within a dis-
tance of 10 mm of an original mapping point. The threshold of 10 mm was
chosen to delineate electrically inactive regions (e.g. superior/inferior caval
veins, pulmonary veins) from the chamber body and is analogous to setting
a similar value as the colour fill threshold of the EAM platform.
Data analysis and statistics
Custom software was written for determining the optimal LAT sampling
point density (MATLAB 8.2, The Mathworks Inc., Natick, MA). Data ana-
lysis was performed using Prism version 6.0c (GraphPad Software, San
Diego, California, USA). Results are presented as mean ± SD. Student’s
unpaired t-test was used to compare group means. Multiple comparisons
were performed with the one-way analysis of variance (ANOVA).
Proportions in two or more groups were compared with the Chi-square
test. A significance level of P< 0.05 was considered statistically significant.
Results
Clinical left atrial tachycardias
Local activation time maps representing 21 left atrial activation
patterns were studied including focal activation (n= 8), localized
re-entry (n= 5) and macro-re-entry (n= 8) (see Figure 3). Focal acti-
vation included four maps created during pacing, from the left atrial
appendage (n= 1) and coronary sinus (n= 3). There were no signifi-
cant differences in symptomatology, co-morbidities, or use of anti-
arrhythmic drugs between the groups (Table 1). The mean LA surface
area was 156 ± 44 cm2 with an original sampled point density of
5.6 ± 4.2 points/cm2. Optimal LAT sampling density was lower for
focal tachycardias than both localised re-entry and macro-re-entry
tachycardias (calculated optimal sampling densities 0.67 ± 0.17
points/cm2 for focal tachycardias, 1.05 ± 0.32 points/cm2 for macro-
re-entrant tachycardias and 1.23 ± 0.26 points/cm2 for localized re-
entry, P= 0.0031, Figure 1B). Calculated optimal sampling density was
A B
C D
Figure 2 The process used for determination of optimal LAT sampling density. (A) The process is shown for a focal tachycardia in a 44 cm mono-
layer with fiber orientation of 18 to the x-axis. (B) Activation times are re-sampled at increasing sampling density and regional activation is re-interpolated
to give the resulting ‘down-sampled’ activation maps. Sampling densities (points/cm2) are given above each example map. (C) Mean normalized LAT map
error at each sampling density is calculated by comparing activation times at each node with the original activation times in A. (D) Taking the first-deriva-
tive of the curve in ‘C’ indicates the sampling density at which minimal further improvement in map accuracy is generated.
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insensitive to the selected value of error reduction rate (Table 2).
The focal tachycardia maps re-interpolated at optimal LAT sampling
density (LAT error rate reduction <0.05 ms/node/point) resulted in
correct localization of the foci of earliest activation (Figure 3A). In the
re-entrant tachycardias re-interpolation at optimal LAT sampling
density resulted in the same overall map appearance, with the same
macro-re-entrant circuit remaining identifiable (Figure 3B). However,
some variations in map appearance at the extremes of interpolation
(e.g. beyond the pulmonary vein ostia) were identifiable. The local-
ized re-entrant maps re-interpolated at optimum sampling density
(Figure 3C) were remarkably similar in appearance to the original
maps; but some variations were evident in activation timing extrapo-
lated into the pulmonary veins.
Porcine right atrial activation and
chamber geometry complexity
Eight pre-ablation LAT maps created under proximal CS pacing were
studied. In the absence of ablation, activation proceeded superiorly in
a linear fashion around the tubular right atrium in all cases (Figure 4A).
After incomplete inter-caval linear ablation, a new activation detour
was evident in all maps (Figure 4B, asterisk). Increasing activation pat-
tern complexity, created by ablation, resulted in a significant increase
in the optimal LAT sampling density (0.45 ± 0.13 points/cm2
pre-ablation vs. 0.78 ± 0.17 points/cm2 post-ablation, P= 0.0008,
Figure 4C). Overall, the optimal point sampling density for the
geometrically-simple porcine right atrium was significantly less than
that for the geometrically-complex human left atrium (0.61 ± 0.22
points/cm2 vs. 1.0 ± 0.34 points/cm2, P= 0.0015).
Simulated activation patterns
Four simulated activation patterns were studied (linear, focal, spiral-
wave, and re-entrant activation). Initiation of activation is shown in
Figure 5. Reference LAT maps were created from local activation
times defined at every mesh node, resulting in an extremely high ref-
erence sampling density of 2500 points/cm2. Calculated optimal
LAT sampling densities (Figure 1A) for focal, re-entrant and spiral-
wave activation patterns were 1.09 ± 0.14 points/cm2, 1.44 ± 0.49
points/cm2, and 1.50 ± 0.34 points/cm2, respectively. Linear activation
in a 2-dimensional domain represents a special case where map ac-
curacy is independent of sampling density (Figure 6A).
Examples of re-interpolated isochronal LAT maps at sub-optimal,
optimal, and supra-optimal LAT sampling densities for focal, re-en-
trant, and spiral-wave activation patterns are shown in Figure 6B–D.
For focal activation, sub-optimal sampling resulted in incorrect focus
localization. For re-entrant activation, sub-optimal sampling density
resulted in an activation pattern more consistent with a focal source.
Finally, sub-optimal sampling of spiral-wave activation failed to reveal
rotational activity in the resulting re-interpolated map. In each case
there was limited morphological improvement in the isochronal map
appearances at supra-optimal compared to optimal LAT sampling
densities (Figure 6B–D, third and final columns).
Figure 3 Clinical isochronal local activation time maps. Local activation time (LAT) maps for example clinical tachycardias are shown. Tachycardia
mechanisms (confirmed by response to entrainment manoeuvres and to ablation) are given as headings in each column. (A) focal activation in low
posterior LA; (B) perimitral macro-re-entry; (C) localized anterior re-entry. Anterior-posterior and posterior-anterior projections are shown (top
and bottom row respectively). Left-most maps of each pair are the original isochronal maps produced at the time of the clinical procedure with pur-
ple dots representing sampled LAT point locations. Right-most maps of each pair are single examples of re-interpolated maps generated at the calcu-
lated optimal densities with black dots representing the re-sampled point locations. MV indicates the mitral valve annulus; * indicates the site of focal
activation.
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Discussion
The main findings of this study are: (1) optimal LAT sampling densities
can be identified for a variety of tachycardia mechanisms to maximize
the diagnostic yield of interpolated local activation time maps, with a
minimal sampling density of 1.0–1.5 points/cm2 identified for optimal
interpolation of accurate LAT maps; (2) optimal LAT sampling dens-
ity is dependent on activation pattern with greater sampling densities
required to correctly reveal more complicated activation sequences
including macro-re-entry and spiral-wave activation; and (3) optimal
LAT sampling density is also dependent on chamber geometry, with
increasing geometric complexity necessitating an increased optimal
LAT sampling density.
The aim of tachycardia activation mapping is 2-fold: to determine
the tachycardia mechanism and thereby inform an ablation strategy.
The ablation target is determined by the site of tachycardia origin
(focal mechanism) or the location of a critical isthmus of conduction
(re-entrant mechanism). Local activation time mapping should be
supplemented by consideration of the response to entrainment man-
oeuvres and more importantly the response to ablation when con-
firming the final tachycardia mechanism. Not infrequently, local
activation time maps (which depend on choice of an adequate refer-
ence, window of interest and appropriate electrogram annotation)
may produce conflicting information. In this context, understanding
the mapping density required to achieve optimal sampling of the
arrhythmia mechanism is crucial in optimising diagnostic yield of map-
ping prior to selection of an ablation target. Three-dimensional elec-
tro-anatomic mapping systems provide a framework for visualization
of electrical activation sequences as an aid to identifying the tachycar-
dia mechanism and corresponding ablation target. Recent techno-
logical advances have enabled significant increases in the spatial
resolution achievable within reasonable timescales with both estab-
lished10 and emerging11 contact mapping platforms.
Whilst high sampling density is clearly important for substrate-
mapping accuracy, for example in identifying areas of low voltage or
fractionated signals important to arrhythmogenesis,12,13 it is uncertain
if high-resolution mapping results in clinical benefit during activation
mapping, where the primary aim is to reliably identify the tachycardia
mechanism. Indeed high-resolution activation mapping is at odds with
earlier strategies aiming to minimize procedure time without impact-
ing success by providing a logical framework for directing the acquisi-
tion of LAT points.14 To this end, we have shown that in systems using
interpolation methods to create isochronal LAT maps from a number
of sampled LAT times, a theoretical maximal sampling density is
reached at which further clinically-relevant improvements in LAT
map accuracy are minimal. By using both simulated data in addition
to clinical data, we have demonstrated that this maximal sampling
density is within the same range (1.0–1.5 points/cm2) irrespective of
the resolution at which the ‘gold standard’ activation sequence is
defined.
1cm
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Figure 4 Porcine right atrial LAT maps. (A) Pre-ablation LAT shows uniform activation across the chamber from coronary sinus towards the right
atrial appendage. (B) Post-ablation LAT shows a new activation detour (asterisk) via the mid-chamber gap in the ablation line. Ablation points are
shown with red tags and catheter positions during ablation with pink dots using the Visitag Carto3 module. (C) Comparison between optimal LAT
sampling density for pre- and post-ablation LAT maps.
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In performing this analysis, distributions of mapping points at a
range of sampling densities were used to identify the global density at
which further sampling yielded minimal improvement in activation
map accuracy. In doing so, a random distribution of ‘re-sampling’
points was used for the following reasons. First, given the flexible na-
ture of mapping catheters the spatial distribution of clinical mapping
points is non-uniform. Secondly, the endocardial surface of the atrium
is irregular resulting in non-uniform spatial distribution of mapped
points even with uniform catheter electrode spacing. Finally, by re-
peating the randomization multiple times, and calculating error for
each repeated interpolated activation map the overall calculated opti-
mal density should be independent of variations in the spatial
distribution of re-sampling points. Nevertheless, non-uniform activa-
tion mapping is likely to be important in certain clinical circumstances
(e.g. focal tachycardias—see below).
The identification of atrial spiral-waves has received renewed at-
tention recently as a strategy to identify ablation targets in atrial fibril-
lation.15 Whilst rotors have been identified in animal16 and computer
models17 of atrial activation, there is some debate as to which tech-
nologies can reliably detect the occurrence of rotational activity
in vivo.18,19 Clinical approaches to identifying rotors typically involve
phase mapping in order to average activation over many cardiac
cycles. This approach has successfully identified rotors in the left
atrium using a 64-pole basket catheter.15 Taking the left atrial
....................................................................................................................................................................................................................
Table 1 Patient characteristics
Focal activation Localized re-entry Macro re-entry P
(n5 8) (n5 5) (n5 8)
Symptoms
Palpitations 8 (100%) 3 (60.0%) 7 (87.5%) 0.1317
Breathlessness 0 (0.0%) 1 (20.0%) 2 (25.0%) 0.3301
Tachycardia-associated cardiomyopathy 0 (0.0%) 1 (20.0%) 1 (12.5%) 0.4581
Co-morbidities
Atrial fibrillation 7 (87.5%) 5 (100%) 7 (87.5%) 0.7079
Hypertension 2 (25.0%) 2 (40.0%) 2 (25.0%) 0.8106
Diabetes mellitus 0 (0.0%) 1 (20.0%) 1 (12.55) 0.4581
Stroke/TIA 1 (12.5%) 0 (0.0%) 0 (0.0%) 0.4261
Vascular disease 0 (0.0%) 0 (0.0%) 0 (0.0%) n/a
Heart failure 0 (0.0%) 0 (0.0%) 0 (0.0%) n/a
Coronary artery disease 1 (12.5%) 0 (0.0%) 1 (12.5%) 0.7079
Valve disease 1 (12.5%) 1 (20.0%) 0 (0.0%) 0.4581
COPD 1 (12.5%) 0 (0.0%) 0 (0.0%) 0.4261
Hypo/hyperthyroidism 1 (12.5%) 1 (20.0%) 0 (0.0%) 0.4581
Echocardiography
LVEF (%) 62.5 ± 2.7% 58 ± 11.0% 53.3 ± 10.8% 0.2361
LA diameter (cm) 4.3 ± 1.1 cm 5.0 ± 1.1 cm 4.4 ± 0.6 cm 0.1179
LA area (cm2) 25.6 ± 5.5 cm2 31.6 ± 3.8 cm2 24.8 ± 5.7 cm2 0.1321
Prior Ablation 4 (50.0%) 5 (100%) 8 (100%) 0.0180 *
Antiarrhythmic drugs
Current AAD use 3 (37.5%) 0 (0.0%) 3 (37.5%) 0.2691
AAD Flecainide 3 Flecainide 1, Sotalol 2
TIA, transient ischaemic attack; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; AAD, antiarrhythmic drug.
....................................................................................................................................................................................................................
Table 2 Sensitivity of optimal sampling density to chosen error reduction rate threshold
ERR OSD Sensitivity 1/Sensitivity
(ms/node/Ddensity) (points/cm2) (›OSD/›ERR)
Focal tachycardia 0.05 0.67±0.17 0.057±0.024 18
Macro-re-entry 0.05 1.05±0.32 0.052±0.022 19
Localized re-entry 0.05 1.23±0.26 0.057±0.018 18
Throughout this study an Error Reduction Rate (ERR) of 0.05 ms/node/Ddensity is taken to represent the density at which further sampling offers limited improvement in inter-
polated LAT map accuracy (termed optimal sampling density, OSD). The sensitivity of OSD to changes in choice of ERR are presented as the derivative of OSD with respect to
ERR. The final column (1/Sensitivity) indicates the change in ERR that would result in a change in OSD of 1 point/cm2.
Atrial tachycardia mapping density e17
Downloaded from https://academic.oup.com/europace/article-abstract/20/2/e11/3098571
by Kings College London user
on 06 March 2018
endocardial surface area to be 150 cm2 (as in this study) and assuming
maximal electrode contact, this equates to a sampling density of 0.43
points/cm2. A recent analysis using the basket catheter found a mean
of only 31 electrodes provided interpretable electrograms.20
Suboptimal contact therefore results in lower sampling densities (e.g.
56 electrodes equates to 0.37 points/cm2, 48 electrodes to 0.32
points/cm2, and 32 electrodes to 0.21 points/cm2). All of these den-
sities are below the optimal LAT sampling density for spiral-wave ac-
tivity identified in this study. Of note an alternative approach using
dynamic voltage mapping applied to identical clinical data failed to
identify sustained rotational activity in 100% (n= 11) of cases.19 This
result is consistent with our finding that a significantly higher sampling
density of around 1.5 points/cm2 should be required to optimally re-
produce spiral-wave activity from known local activation time points.
The results presented here should not be interpreted to indicate
that sampling densities above 1.5 points/cm2 are never of clinical
benefit in activation mapping. One limitation of the ‘optimally’
resampled clinical maps shown in Figure 3 is that interpolation at re-
gions distant to the body of points (e.g. extending into the pulmonary
veins or LAA) may be inaccurate. Furthermore a local density of >1.5
points/cm2 may well be required to correctly identify the origin of
focal or localised-re-entrant tachycardias. Such variable distributions
Figure 5 Initiation of activation patterns in the atrial monolayer. (A) Linear activation; (B) focal activation; (C) re-entrant activation; and (D) spiral
wave activation. Stimulated regions are shown in white in the left-most column of each row.
e18 S.E. Williams et al.
Downloaded from https://academic.oup.com/europace/article-abstract/20/2/e11/3098571
by Kings College London user
on 06 March 2018
of mapping points have not been examined in this study. Rather, the
results of this study support the hypothesis that once an upper global
sampling density of 1.5 points/cm2 has been reached (equivalent to
around 225 points for a typical LA with endocardial surface area of
150 cm2) then tachycardia mechanisms should be evident or strongly
suggested, and, if so, subjected to further testing which may include
more detailed activation mapping (for candidate focal or localized re-
entry mechanisms) or entrainment mapping (for candidate macro-re-
entry mechanisms). Furthermore, where the site of earliest activation
through an incomplete linear lesion is sought, higher density mapping
at the planned ablation target may be of benefit.4
Limitations
Whilst this study has assessed mapping density for atrial arrhythmia con-
tact mapping using typical electrode sizes/configurations used in clinical
practice, the impact of alternative electrode size on optimal sampling
density has not been examined and should be addressed in future stud-
ies. The clinical population studied in this manuscript is small and repre-
sents a select group of patients. In particular, we highlight (Table 1) that
the cases were characterised by mild underlying structural heart disease
and were predominantly cases having undergone prior ablation.
Conclusions
In conclusion, this work demonstrates that for commonly-
encountered clinical tachycardia mechanisms the majority of informa-
tion discernible from LAT maps can be obtained with a limited
sampling density strategy. The exact sampling density required de-
pends on tachycardia mechanism and clinical characteristics but is in
the range of 1.0–1.5 points/cm2. In the event where candidate mech-
anisms are not identifiable at this sampling density, rather than col-
lecting further points a better approach may be to begin a new
activation map perhaps with a different window of interest, reference
electrogram, or LAT assignment technique.
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Figure 6 Simulated isochronal local activation time maps. (A) Linear activation; (B) focal activation; (C) re-entrant activation; and (D) spiral wave ac-
tivation. Reference LAT maps are shown in the left most column. In A and B, local activation time is taken as the first activation of each node. In C and
D, a window of interest (WOI) incorporating 100% of the tachycardia cycle length (TCL) was specified. Grey colour represents tissue that is never
activated during the WOI—either non-conducting (C) or functionally refractory (D).
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